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The insulin-like growth factor 2 (Igf2) gene encodes a potent growth factor that is expressed in multiple tissues during embryonic
development. Expression at this locus is mediated by genomic imprinting. In the developing endodermal tissues, imprinting of Igf2 is
mediated by the interaction of a set of enhancers downstream of the linked H19 gene with a differentially methylated domain (DMD) that lies
approximately 2–4 kb upstream of H19 that has a boundary or insulator function in the hypomethylated state. In the remainder of tissues that
express Igf2 and H19, the cis elements that drive their correct expression and imprinting are not well understood. In addition, enhancers
driving expression of Igf2 in the choroid plexus and leptomeninges, tissues where the gene is thought not to be imprinted, have not been
isolated. Here we show that biallelic (non-imprinted) expression within the choroid plexus is restricted to the epithelium, and we provide
evidence that a conserved intergenic region functions as an enhancer for Igf2 both in tissues where the gene is imprinted, and where Igf2 is
biallelically expressed. The presence of an enhancer for imprinted tissues in the intergenic region argues for the existence of imprinting
controls distinct from the DMD, which may be provided by differential methylation at sites proximal to Igf2.
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characterized by Koide et al. (1994) as a GC-rich, relatively
unmethylated region approximately 32 kb upstream of the
mouse H19 gene. This region was found to contain DNaseI
hypersensitive sites (HSS) as well as a high degree of
sequence conservation between mammals, a strong indica-
tion that this region is functional. Subsequent analysis (Ain-
scough et al., 2000) showed that this region can be subdivided
into two domains based on comparisons with human se-
quence (see Fig. 1c, shaded areas). Region 1 shares 86%
identity between mouse and human sequences over approx-
imately 100 bp and contains the previously mapped HSS.
Region 2 displays 87% identity between the two species over
approximately 200 bp. Region 1 has been analyzed in the
context of a yeast artificial chromosome (YAC) transgene that
contains 130 kb of the mouse genomic region spanning from
approximately 5 kb upstream of the first exon of insulin-like
growth factor 2 (Igf2) to approximately 35 kb downstream of
Fig. 1. The Igf2/H19 gene locus and P3-LacZ-CCD transgene construct. (a) The relative positions of the Igf2 and H19 genes within the 100 kb genomic region
are indicated by their position along the horizontal line. Exons are indicated by filled boxes and regulatory elements by open boxes. Vertical arrows above the
line indicate regions of DNaseI hypersensitivity. Horizontal arrows show the direction of transcription from the four Igf2 promoters (P0, P1, P2, and P3) and the
single H19 promoter. Regions that exhibit differential levels of methylation between parental alleles (DMRs, DMD, and H19 promoter-proximal region) are
indicated by solid horizontal lines. (b) Structure of the P3-LacZ-CCD transgene (Construct C). Igf2 promoter 3 was cloned upstream of the E. coli LacZ coding
sequence, and the 2 kb CCD region was inserted immediately downstream. (c) The CCD in detail. The 2 kb CCD regions contains two regions of strong
sequence conservation with the human locus, Regions 1 and 2 (see text). The CCD deletion in the YAC experiment (Ainscough et al., 2000) referred to in the
text is the 5V 1 kb EcoRI (E)–PstI (P) interval containing Region 1.
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maintained of both an Igf2-LacZ fusion gene and H19, and
transgenic mice display expression of both genes in the
majority of tissues where Igf2 and H19 are normally
expressed (Ainscough et al., 1997). In transgenic mice where
1 kb of the intergenic region, including Region 1 but not
Region 2, was deleted from the sameYAC, the maternal allele
of LacZwas reactivated in late gestation in a subset of skeletal
muscle cells, most notably those of the tongue (Ainscough et
al., 2000). Region 1 therefore contains a maternal allele-
specific, tissue-specific silencer that is active in late gestation.
The role of Region 2 has not been elucidated, though
evidence from transgenic and germline knock out experi-
ments suggests that it may contain the exchange tissue
enhancers (Jones et al., 2001; Ward et al., 1997).
Imprinting of the Igf2 gene in endodermal tissues is
thought to be mediated by the interaction of tissue-specific
enhancer elements with a differentially methylated domain
(DMD) 2–4 kb upstream of the H19 gene (for relative
positions, see Fig. 1). On the maternal allele, where the
DMD is unmethylated, it functions as a boundary to prevent
the access of downstream enhancers to the Igf2 gene. This
boundary function is mediated by the protein CTCF (Bell and
Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000; Pant
et al., 2003; Szabo et al., 2000). On the paternal allele,methylation of the DMD prevents CTCF binding; therefore,
the Igf2 promoters and the downstream enhancers are able to
interact. If the DMD provides the sole imprinting element for
Igf2, a prediction would be that the enhancers that drive
imprinted Igf2 expression would lie on the opposite side of
the boundary. Indeed, a region that can drive gene expression
in skeletal muscle, where Igf2 is abundantly expressed and
imprinted, has recently been mapped as lying approximately
28–30 kb downstream of theH19 gene, on the predicted side
of the boundary (Kaffer et al., 2000), and is one of many
putative enhancers in this region (Davies et al., 2002; Ishihara
et al., 2000). However, the existence of several regions of
differential methylation proximal to Igf2 (DMR0, DMR1,
DMR2, see Fig. 1) that display methylation-dependent,
tissue-specific silencer activity (Constancia et al., 2000; Eden
et al., 2001; Murrell et al., 2001) argues that the DMD may
not directly mediate the imprinting of Igf2 in all tissues.
The CCD lies between the Igf2 gene and the DMD and
consequently the CCD should not be affected by the
boundary element that prevents the interaction of Igf2 with
more distant enhancers. We therefore considered the CCD
as a good candidate for driving expression in the tissues
where Igf2 is biallelically expressed, the choroid plexus
and leptomeninges. To test this hypothesis, we have created
transgenic mice that carry the CCD in the context of a
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the reporter gene in the exchange tissues of the brain. We
show that within the choroid plexus endogenous, Igf2
expression is imprinted in the stromal compartment (with
the paternal allele active) but non-imprinted in the epithe-
lium (both alleles expressed), and that this is opposite to
the pattern of H19 expression (with the maternal allele
expressed in the stroma and both alleles silent in epitheli-
um). The CCD was able to drive transgene expression in
both stromal and epithelial components of the choroid
plexus in a pattern very similar to that of endogenous
Igf2 expression. In addition, the CCD was able to repro-
ducibly drive gene expression in further tissues of meso-
dermal or neural crest origin that are consistent with the
known expression pattern of Igf2. The presence of an
enhancer for Igf2 proximal to the boundary, in addition
to the existence of tissue-specific silencers upstream of the
Igf2 gene, suggests that a second mechanism acts to
imprint this gene in a subset of tissues.Methods
Mice
The LacZDMR2 mice were maintained on an F1
(CBA  C57BL6/J) background. To derive embryos for
allele-specific expression analysis, male and female mice
heterozygous for the LacZDMR2 mutation were mated
with F1 partners. To distinguish LacZDMR2
 heterozy-
gous embryos from wild-type littermates, yolk sacs were
collected and crude lysates were made by heating in 50
mM NaOH at 100jC for 10 min. Lysates were analyzed
for the presence of the LacZ reporter by PCR using
primers internal to the LacZ gene: 407, 5V ATG AAC
GGT CTG GTC TTT GC-3V and 408, 5V ACA TCC AGA
GGC ACT TCA CC-3V. The H19 knockout strain, desig-
nated H19D3, was previously described, together with
methods for distinguishing the wild-type and knockout
alleles (Ripoche et al., 1997).
Transgenesis
The P3-LacZ-CCD construct C (see Fig. 1) contained a
3.6 kb coding region of the bacterial h-galactosidase (Lac
Z) gene driven from Igf2 promoter 3 (Igf2 P3, as de-
scribed in Caricasole and Ward, 1993). The CCD frag-
ment, placed immediately 3V to the LacZ gene, was a 2 kb
EcoRI fragment (pA-4, as detailed in Koide et al., 1994).
Cloning steps were performed in the Bluescript II SK+
vector, according to standard techniques (Sambrook et al.,
1989).
Transgenic mouse lines were constructed as follows:
Linear construct DNA (1 Ag/ml) was purified from vector
sequences and microinjected into one pronucleus of an F1
(C57BL/6JxCBA/Ca) zygote, using standard techniques(Hogan et al., 1986). Injected embryos were transferred into
the oviduct of pseudopregnant MF1 females. Lines were
established and maintained by breeding the transgenics with
F1 partners.
Founders were identified by PCR of sequences unique to
the Igf2 P3-LacZ-CCD transgene (primers Igf2 P3: 5V
CTGTGAGAACCTTCCAGCCTTTTC 3V and LacZ: 5V
CAAGGCGATTAAGTTGGGTAACGCC 3V) and con-
firmed by Southern blotting of tail genomic DNA with a
probe generated from the transgene construct, according to
standard techniques. Copy number was estimated on South-
ern blots by titrating DNA from hemizygous transgenic
animals, with reference to an endogenous band detected
using CCD sequences within the transgene probe.
Tissue processing
Embryos and tissues were analyzed for LacZ expression
according to Ainscough et al. (2000), with the following
modifications: Samples were incubated in X-Gal or BLU-
GAL (Melford Laboratories Ltd) staining solution for 16–
24 h, washed with PBS, then fixed overnight in 4%
paraformaldehyde in PBS (PFA) and stored in 70% ethanol.
Paraformaldehyde fixed material from both LacZ analysis
and obtained for in situ hybridization analysis was pro-
cessed according to standard techniques as described pre-
viously (Charalambous et al., 2003).
Probes and antibodies
The H19 in situ hybridization probe was a 346 bp
fragment spanning exons 3–4 of the mouse H19 cDNA,
amplified by PCR using the following primers: 416; 5VAAT
GAG TTT CTA GGG AGG GAG G-3V and 417; 5VGGA
AAA GTG AAA GAA CAG ACG G-3V, then cloned into
the pGEM-T easy vector. Sense and antisense transcripts
were obtained for this gene and for Igf2, as described
previously (Charalambous et al., 2003). Transthyretin
(TTR) was detected in tissue sections using a rabbit poly-
clonal antiserum (DAKO) at a dilution of 1:100. Immuno-
histochemistry and mRNA in situ hybridizations were
performed essentially as detailed in Charalambous et al.
(2003).Results
Generation of P3-LacZ-CCD transgenic mice
To test the CCD function, we created a transgene
construct containing the LacZ gene driven by Igf2 promoter
3 (P3), in cis to the CCD (construct C, see Fig. 1). Previous
experiments have shown that Igf2 P3 alone cannot drive
reproducible tissue-specific expression of a reporter gene
(Ishihara et al., 2000; Ward et al., 1997). Construct C (P3-
LacZ-CCD) DNA was used to generate five transgenic
Fig. 2. Expression of the P3-LacZ-CCD transgene construct mirrors that of
Igf2 in the brain. (a) Bisected embryo at e14.5 of the Columbo line,
focusing on the area surrounding the fourth ventricle of the brain. The
choroid plexus (cp) is expressing the reporter gene, as are the connecting
leptomeninges (le) surrounding the brain. The leptomeninges that enclose
the neural tube also express the transgene. Some additional gene
expression is seen in the pons (p), which is limited to the Columbo line
and thought to be due to a position effect of transgene integration. (b)
Dissected fourth ventricle choroid plexus at 10 days post-partum from the
Columbo line. Gene expression can clearly be seen in the connective
stromal tissue (s) as well as in a subset of epithelial (ep) cells. (c and d)
Whole brain from the individual shown in b. Gene expression is confined
to the meningeal layers surrounding the brain and its cavities. (e–h) A
comparison of reporter gene expression from the Columbo line, and Igf2
mRNA localization at e15.5. (e, g) Show in situ hybridization to the fourth
ventricle choroid plexus with an antisense Igf2 probe at 100 and 200
magnification, respectively. (f, h) Show reporter gene expression in the
fourth ventricle at the same magnification. Both Igf2 and reporter gene
expression is abundant in the stroma and leptomeninges, and is less
abundant and mosaic in the choroid plexus epithelium.
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Christian, and Clive, all of which were shown by PCR and
Southern blotting to transmit the transgene (data not
shown). Founder animals were mated to generate an F1
generation of males and females hemizygous for the trans-
gene, and these animals were backcrossed onto stock
(CBA/C57BL6) mice to yield the embryos used in this
study. Embryos were assayed for the expression of h-
galactosidase by an in situ assay at various embryonic
and neonatal stages. Within each line, no differences in
spatial patterns of gene expression, or obvious differences
in the level of gene expression, were observed following
the transmission of the transgene from either males or
females at any developmental stage examined (not shown).
This is consistent with the absence of parental allele-
specific methylation or DNaseI hypersensitivity in the
CCD (Koide et al., 1994).
P3-LacZ-CCD reporter transgenes are expressed in tissues
where Igf2 is biallelically expressed
Four of five lines demonstrated a detectable level of
gene expression from embryonic day 12.5 (e12.5). In the
Clive line, the transgene appears to have been silenced by
a position effect. As expected, the remaining lines dis-
played reporter gene expression in the choroid plexus and
leptomeninges from their formation at e12.5. Embryos
from the Connie line expressed the transgene at very
low levels, and not all individuals positive for the trans-
gene demonstrated detectable levels of expression. The
Connie line was therefore excluded from further analysis.
By e14.5, the Columbo, Cornelius, and Christian lines all
expressed the transgene reproducibly in the third, fourth,
and lateral ventricle choroid plexus, as well as in the
leptomeninges of the brain, and surrounding the spinal
cord (Fig. 2a). Expression of the reporter gene in the
choroid plexus and leptomeninges was maintained
throughout embryonic development and persisted after
birth (Figs. 2b–d), consistent with the previously reported
endogenous Igf2 expression pattern (Stylianpoulou et al.,
1988b).
The choroid plexus develops from more than one cell
population. It is comprised of a stromal stalk that extends
into the ventricular cavities of the brain, surrounded by the
columnar choroid plexus epithelium. The stroma develops
from the same mesenchymal cell population as will form
the pia mater of the leptomeninges, some of which may be
derived from the neural crest (Catala, 1998; Davson, 1967).
At approximately e10.5 in the mouse, mesenchymal cells
overlying the neuroepithelium expand and become highly
populated with vasculature. This expansion into the ven-
tricles forms a stromal stalk that retains its ependymal
lining. The ependyma is the innermost layer of the neuro-
epithelium that lines the ventricles of the brain and the
spinal cord. Concomitant with the expansion and invagi-
nation of the stroma, the ependyma in this region alsoexpands, becoming highly convoluted by e12.5. The mor-
phology of the cells changes from low cuboidal to a high
cylindrical epithelium with an apical brush border (Davson,
1967), the choroid plexus epithelium.
The expression pattern of the reporter gene was com-
pared in detail with that of Igf2 mRNA at mid-gestation. In
the fourth ventricle of the brain, both Igf2 and the reporter
gene were expressed at high levels in the stromal stalk of the
choroid plexus, and in the underlying pia mater and arach-
noid mater layers of the leptomeninges (Figs. 2e, f). At
higher magnification (Figs. 2g, h), a lower level of reporter
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distribution in the outer epithelial layer of the choroid
plexus. Therefore, reporter constructs mirror the expression
of Igf2 in both the fine distribution of gene expression
within the exchange tissues, and in the maintenance of gene
expression in these tissues after birth.
Igf2 is biallelically expressed in the choroid plexus
epithelium, but imprinted in the stroma
Expression of Igf2 has been previously reported in both
the stroma and the choroid plexus epithelium (StylianpoulouFig. 3. Igf2 demonstrates both monoallelic and biallelic expression in the choroid
allele is detectable from both parental alleles at developmental stages spanning the
the reporter is present in both a scattered population of ependymal cells (the presum
presumptive choroid plexus stroma, s). (B) At the same stage, reporter gene expre
ependymal cells, but absent from the overlying mesenchyme. Expression was not
the Igf2 LacZDMR2 allele. (D, G) At e12.5 to e14.5, reporter gene expression fr
(E, H) However, following maternal transmission of LacZDMR2, reporter gene
pattern of parental allele-specific gene expression was observed by in situ hybridiza
(C, F, and I) An antibody recognizing transthyretin (TTR) protein was used as a m
TTR (brown stain) throughout the plexus epithelium at all stages examined. (J) H1
epithelium, of a wild-type embryo at e14.5. (K) Following maternal transmissio
compartment of the choroid plexus. Tissue sections were counter-stained with eithe
I), and images were captured at a magnification of either 400 (A– I) or 200 (et al., 1988b). However, whether the gene is biallelically
expressed in both compartments has never been resolved
(Svensson et al., 1995). In addition, it is not known whether
the expression of the gene is initially parent-of-origin
specific in this organ, becoming biallelic as development
proceeds, or expressed from both alleles from the onset of
development.
To answer these questions, we made use of a previously
described allele of Igf2 in which exons 4–6 (including
DMR2) are replaced with a LacZ cassette. This
LacZDMR2 allele faithfully recapitulates the expression
of Igf2 (Murrell et al., 2001). We followed the expression ofplexus. Reporter gene expression (blue stain) from the Igf2 LacZDMR2
course of choroid plexus development. (A) At e10.5, paternal expression of
ptive choroid plexus epithelium, ep) and in the overlying mesenchyme (the
ssion from the maternal allele is present in a similar scattered population of
detected before e10.5, either following maternal or paternal transmission of
om the paternal allele is detectable in both the epithelium and in the stroma.
expression is detected in the epithelium, but never in the stroma. A similar
tion for the wild-type Igf2 allele in LacZDMR2 heterozygotes (not shown).
arker of developing choroid plexus tissue and shows uniform expression of
9 mRNA can be readily detected in the choroid plexus stroma, but not in the
n of the H19D3 allele, H19 gene expression cannot be detected in either
r nuclear fast red (A, B, D, E, G, and H) or Mayer’s hematoxylin (C, F, and
J, K).
Table 1
Summary of transgene copy number and expression at e14.5 across the P3-
LacZ-CCD transgenic lines
Line Copy
number
Embryos
examined
Position-
dependent sites
of gene
expression
at e14.5
Common sites
of gene
expression
at e14.5
Connie 2–4 48 none detected choroid plexus
(fourth ventricle)
Columbo >20 25 oculomotor nerve,
pons, roof of
midbrain,
abdominal wall
muscle, mullerian
tubicle, floorplate
leptomeninges
(roof of midbrain
and surrounding
the third ventricle,
and surrounding
the neural tube),
Cornelius 2–4 52 trigeminal and
facial ganglia,
dorsal root
ganglia, and
peripheral ganglia
(including those
of the limbs)
choroid plexus
(of the third,
fourth, and
lateral ventricles),
lens of eye,
tongue muscle,
mesenchyme of
Christian >20 34 cartilage of the
digits, tubules
of the kidney,
dermis of the skin
the head and
neck tubules of
the ear (eustacian
tubules and lateral
and posterior
semicircular
canal), ureter and
degenerating
mesonephros
Clive 1–2 24 none detected none detected
For each of the P3-LacZ-CCD transgenic lines, an estimation of transgene
copy is given and also the number of embryos examined for expression of
the LacZ reporter. Common sites of expression are those regions where the
transgenes were expressed in the majority of lines. Position-dependent sites
of expression were those unique to a transgenic line.
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embryos from e9.5 to e14.5 to ask whether Igf2 is expressed
from the earliest formation of the organ in both epithelial
and stromal compartments. In addition, we were able to
determine the imprinting status of Igf2 in both compart-
ments by examining embryos that had inherited the
LacZDMR2 allele uniparentally. Before e10.5, we could
not detect reporter gene expression in either ependymal cells
or in the underlying mesenchyme, following maternal or
paternal transmission of LacZDMR2 (not shown). At
e10.5, paternal gene expression was detected in both the
mesenchyme and in a subset of the overlying ependymal
cells of the presumptive choroid plexus (Fig. 3a). At the
same stage, expression from the maternal allele was detect-
able only in the ependyma (Fig. 3b). Subsequently, pater-
nally derived gene expression was abundant in the
developing stroma (Figs. 3d, g), whereas the maternally
derived reporter gene expression could not be detected in
this region (Figs. 3e, h). Gene expression from both parental
alleles was detected in the choroid plexus epithelium. In
contrast, H19 mRNAwas detected in the stroma but not the
epithelium of a wild-type embryo at e14.5 (Fig. 3j), and was
absent from both cell types in embryos with maternal
transmission of an H19D3 knockout allele (Fig. 3k). To
confirm that Igf2 expression is associated with the choroid
plexus, particularly at earlier stages when the characteristic-
folded morphology of this organ has not been established,
we have used an antibody that recognizes transthyretin
(TTR). Within the brain, TTR expression was confined to
the presumptive and definitive choroid plexus epithelium,
with expression commencing at around e10.5 when the
plexus epithelial cells differentiate from the neuroepithe-
lium. This expression pattern is consistent with the previous
description of TTR as a marker of choroid plexus epithelium
(Murakami et al., 1987). It is noted that TTR expression is
uniform throughout the epithelium, in contrast with the
variegated expression of Igf2 in this tissue.
We conclude that Igf2 is expressed in both the epithelial
and stromal compartments of the choroid plexus from the
onset of its development. Igf2 is imprinted (paternally
expressed) in stromal cells, but biallelically expressed in
the choroid plexus epithelium. H19 has a reciprocal expres-
sion pattern in the choroid plexus with expression from the
maternally derived allele in the stroma and with both alleles
silent in the epithelium. The CCD was thus able to drive
reporter gene expression in a region where Igf2 is bialleli-
cally expressed, as predicted, but also in a region where the
gene is imprinted.
P3-LacZ-CCD reporter transgenes are expressed in further
tissues where Igf2 is imprinted
Further examination of CCD-bearing transgenics
revealed gene expression in some additional embryonic
tissues. The three high expressing lines (Columbo, Corne-
lius, and Christian) demonstrated reproducible patterns ofgene expression in structures derived from the mesoderm
and the neural crest (summarized in Table 1), as well as
several line-specific sites of expression that are a presumed
consequence of the transgene insertion sites (position
effects).
At e9.5, all three lines showed staining in the mesen-
chyme at the site of the head fold, in the developing eye,
and in the branchial arches. A subset of the condensing
paraxial mesoderm was stained, as was the urogenital
ridge (Fig. 4b). By e10.5, a high level of staining was
observed in the somites at their dorsolateral edge, in the
mesenchyme surrounding the myencephalon including that
which condenses to form the pia and arachnoid mem-
branes of the leptomeninges (Rugh, 1990; Stylianpoulou et
al., 1988a), as well as in the mesenchyme surrounding the
neural tube (Fig. 4c). The mesonephros maintained ex-
pression of the reporter gene, and the developing eye was
clearly stained. At e12.5 (Fig. 4f), expression in the
paraxial mesoderm had declined and was present only in
the most posterior somites. Gene expression was wide-
Fig. 4. Expression of the C construct in tissues where Igf2 is imprinted. Representative embryos from the Columbo line are shown at e9.5 (b), e10.5 (c), e12.5
(e, f), and at e14.5 (g) with reference to Igf2 expression at e10 (a) and e12.5 (d). In the early embryo (a–c), the transgene is expressed in the head mesenchyme
(me), in the branchial arches (ba), in a subset of the somitic mesoderm (so), and in the eye (ey). By e12.5 (d– f), this expression has become refined to the
ependyma of the brain (me), the lens of the eye (ey), several regions of facial mesenchyme, to the posterior somites (dm), and the mesonephros (not shown). In
later development (g), facial mesenchymal expression is resolved into specific areas including the tongue (to), the nasal epithelium (ne), and the ear (not
shown).
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present in the choroid plexus as it forms in the fourth
ventricle. Cranial structures such as the eustachian tubules
and semicircular canals of the ear, and the nasal mesen-
chyme and epithelium began to express the transgene at
this stage, as did the intrinsic muscle of the tongue (Fig.
4e). Expression was maintained in the mesonephros and in
the eye (not shown). At e14.5, gene expression was lost
from the derivatives of the somites. The tongue muscle,
nasal epithelium and mesenchyme, ear and neck cartilage
expressed the transgene (Fig. 4g). The mesonephros has
degenerated at this stage, but one of its derivatives, the
ureter, displayed reporter gene expression (not shown).
The choroid plexus and meninges surrounding the brain
and spinal cord continued to express the transgene, and we
note that within the choroid plexus epithelium expression
is restricted to a subset of cells, as is expression of
endogenous Igf2 (see Fig. 3). After e14.5, gene expression
declined in all tissues except the exchange tissues of the
brain (Fig. 2c).
In summary, reproducible expression patterns were seen
in three transgenic mouse lines containing the C construct,
representing three independent integration events. This
expression pattern represents a subset of the tissues in which
Igf2 is expressed during mouse development (see Figs. 4a,
d). Furthermore, in all the tissues described above (with the
exception of the exchange tissues of the brain), the majority
of Igf2 transcripts are generated from the paternal allele of
the gene. The CCD is therefore acting as an enhancer bothin tissues where Igf2 is imprinted and where it is biallelically
expressed.Discussion
We have established that Igf2 expression is biallelic from
the earliest stages at which it can be detected (e10.5) in the
presumptive choroid plexus epithelium. In contrast,
imprinted (paternal-allele) expression is seen from the onset
in choroid plexus stroma. We propose that this reflects the
different origins of these two tissues (Catala, 1998; Davson,
1967), and that epigenetic marks may be differently estab-
lished in these lineages (see Fig. 5). Biallelic methylation of
the differentially methylated regions proximal to Igf2
(DMR1 and DMR2) has been reported previously following
analysis of whole choroid plexus, and the same report
indicated that the H19 promoter exhibits only 50% methyl-
ation, consistent with differential allelic marking of this
region (Feil et al., 1994). The methylation status of the
DMD in this tissue remains unknown, and no attempt has
yet been made to separately analyze methylation in the
stromal and epithelial compartments. However, it is possible
that within the choroid plexus, biallelic methylation of Igf2
DMRs is restricted to the epithelium, and that this local
hypermethylation is permissive for Igf2 expression.
The results of our transgenic experiments using the Igf2
P3-LacZ-CCD construct demonstrate that the CCD can act as
a regional enhancer of a reporter gene during mouse devel-
Fig. 5. Proposed model of Igf2 expression mediated by enhancer activity of
the CCD. The Igf2 and H19 genes (gray boxes, not to scale) are shown
relative to areas thatmay be differentiallymethylated between parental alleles
[black boxes, from left to right Igf2 DMR1 and DMR2, the DMD (2 boxes)
andH19 promoter-proximal region; black lollipops above the boxes indicates
regions of methylation] and enhancers (shown as gray ovals, from left, CCD,
endodermal enhancers and mesodermal enhancers). Curved arrows indicate
interactions between enhancers and promoters. (a) In the choroid plexus
epithelium, the CCD may drive Igf2 expression from the paternal allele and
the maternal allele, as DMR1 methylation prevents the binding of Igf2-
promoter silencing factors such as GCF. H19 is not expressed in the choroid
plexus epithelium, perhaps due to the methylation of its promoter (though
this has yet to be established; see text). (b) In other tissues where the CCD is
active (i.e., CP stroma, somites, tongue, eye), the Igf2 promoter can be
accessed on the paternal allele, due to methylation at DMR1. On the maternal
allele, loss of DMR1 methylation allows the binding of silencing factors that
prevent CCD enhancer activity. In addition, lack of methylation of the DMD
on the maternal allele allows the binding of the boundary protein CTCF,
and thus blocks the Igf2 promoter from access by the distal enhancers.
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(the choroid plexus epithelium) and monoallelically (the
stroma of the choroid plexus and also discrete sites outside
of the brain). It is important to note that the Igf2 P3-LacZ-
CCD transgenes did not exhibit any differences in expression
when transmitted from either males or females, indicating
that the isolated CCD is not sufficient to direct imprinted
expression, a fact that is consistent with the absence from this
region of any parental allele-specific methylation or DNaseI
hypersensitivity (Koide et al., 1994). The enhancer for
choroid plexus expression has previously been predicted to
lie within the interval between Igf2 and H19, both from
transgenic experiments with CCD reporter constructs (Wardet al., 1997), and from a 12 kb deletion, including the CCD,
which showed reduced expression in the choroid plexus
(Jones et al., 2001). The knockout study by Jones et al.
(2001) did not report a reduction in levels of gene expression
in any tissues other than the choroid plexus; however, the
study measured gene expression quantitatively on dissected
organs. Our study shows expression of the reporter gene in
discrete tissues and developmental stages that could easily be
missed by the previous approach. Likewise, deletion of the 5V
1 kb (including Region 1) of the CCD from a YAC transgene
did not result in the loss of gene expression in any of the
tissues that we report, and instead, CCD Region 1 was
associated with a tissue-specific silencer function (Ain-
scough et al., 2000). Consequently, we propose that the
enhancer region most likely lies in the second 1 kb of the
CCD that includes Region 2 (see Fig. 1). This must be
confirmed by testing smaller reporter constructs to exclude
alternative explanations, such as the presence of redundant
enhancers that may have obscured the role of Region 1 in the
YAC experiments. Within the choroid plexus epithelium, the
CCD directed transgene expression in a mosaic fashion to
only a subset of cells, mimicking the endogenous Igf2
expression pattern in this tissue. Interestingly, the silencer
function of the mouse CCD was found to be conserved when
it was tested in transgenic Drosophila and conferred varie-
gated silencing on the mini-white reporter gene, with silenc-
ing dependent upon two polycomb-group proteins (Erhardt
et al., 2003). This suggests a mechanism by which enhancer
and silencer elements within the CCD might interact to bring
about variegated expression of Igf2within the choroid plexus
epithelium.
We propose that a mesodermal or neural crest enhancer
element lies at the CCD, driving the imprinted expression of
Igf2 independently of the Igf2/H19 boundary element. The
Igf2 DMRs have been shown to play a role in the imprinting
of Igf2 in the mesoderm (Constancia et al., 2000; Eden et al.,
2001; Weber et al., 2001). DMR1 contains several CpG
dinucleotides that are hypomethylated on the maternally
derived chromosome, and hypermethylated on the paternally
derived chromosome (Brandeis et al., 1993; Feil et al., 1994;
Sasaki et al., 1992). Differences in the levels of methylation
between parental chromosomes are most marked in tissues
with a substantial mesodermal component (Weber et al.,
2001). A deletion encompassing DMR1, when maternally
inherited, leads to a detectable derepression of the maternal
Igf2 allele from e12 in whole embryos, and from e16 in
individual mesodermal tissues (Constancia et al., 2000). The
authors suggest that DMR1 contains an allele-specific silenc-
er that represses the maternal allele in the mesoderm. An
additional methylation-sensitive silencer has been mapped
within DMR1, but its action is not thought to be tissue-
specific (Eden et al., 2001). It would be of interest to ascertain
if DMR1 can silence gene activity in the subset of meso-
dermal tissues stained in transgenic mice carrying the P3-
LacZ-CCD reporter construct. The presence of enhancers
located upstream of the DMD boundary, combined with
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provide the basis of correct imprinted expression of Igf2 in
some non-endodermal tissues, including the choroid plexus
epithelium (see Fig. 5).
It has been shown recently that methylation of the DMRs
at this locus is coordinated in a hierarchical fashion (Lopes et
al., 2003). Mutations in the DMD, when transmitted mater-
nally, result in loss of differential methylation of both DMR1
and DMR2. Both alleles become highly methylated. More-
over, a maternally transmitted deletion encompassing DMR1
leads to a greater level of methylation of DMR2. Thus, cis-
acting elements are present in the DMD and upstream of Igf2
that act to protect the DMRs from methylation. This work
confirms earlier experiments showing that Igf2-proximal
DMRmethylation is dependent uponDMD sequences (Forne
et al., 1997), but also highlights that perturbations of DMR1
could lead to the relaxation of Igf2 imprinting independently
of the DMD. The DMRs proximal to Igf2 provide an
additional level of imprinting control. In combination with
enhancers proximal to the DMD boundary, these local DMRs
may provide control of Igf2 imprinting that is independent of
the DMD (Fig. 5). We propose that such an enhancer region
lies at the CCD and functions to drive imprinted expression of
Igf2 in a small subset of tissues of mesodermal and neural
crest origin. Other enhancer sequences may also lie within the
interval between the Igf2 promoter and the DMD boundary
(Drewell et al., 2002). The presence of Igf2-proximal
enhancers suggests that a distinct mechanism of Igf2 imprint-
ing has arisen in two subsets of tissues where the gene is
expressed. Mutations in this DMD-independent mechanism
of Igf2 imprinting may account for some of the cases of
Beckwith–Wiedemann syndrome, in which loss of imprint-
ing of Igf2 occurs with no modification of methylation at the
DMD (Engel et al., 2000).Acknowledgments
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